Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Ann Surg. 2016 Oct;264(4):575–584. doi: 10.1097/SLA.0000000000001873

Table 3.

Panel of dysregulated miRNAs and AUC in “Test” cohort for “All neoplasia” vs. “control”, “CR neoplasia” vs. “Other cancers” and “CRC” vs. “CAA”.

Comparison miRNA Area Under the Curve (95% CI)

Any neoplasia vs. control (n=100 vs. 20) miR-21 0.91 (0.85 – 0.96)
miR-29c
miR-346
miR-374a

CR neoplasia vs. other cancers (n=40 vs. 60) miR-21 0.79 (0.70 – 0.88)
miR-29c
miR-372
miR-374a

CRC vs. CAA (n=20 vs. 20) miR-29c 0.98 (0.96 – 1.00)
miR-122
miR-192
miR-374a